The authors of this study concluded, “We do not recommend viscosupplementation for hip osteoarthritis. Compared to placebo, data shows scarce evidence of its efficacy up to 3 months, and suggests no difference at 6 months.”
Archives of Physical Medicine and Rehabilitation
Leite VF, et al.
This meta–analysis intended to evaluate the efficacy of viscosupplementation (HA) in hip osteoarthritis (OA) pain, disability and adverse events. In this systematic review, the researchers did not recommend viscosupplementation for hip OA. Data indicated scarce evidence of its efficacy up to 3 months compared to placebo and suggested no difference at 6 months. However, for short–term symptom relief, future RCTs could present HA as an alternative to methylprednisolone (MPA).
Story Source – may require registration
Journal Abstract